James R. Tobin, Director at TransMedics Group, Inc. (TMDX), sold 97,030 shares at $39.98 ($3.9M) on 2022-07-29, disclosed to the SEC on 2022-08-01.
Open-market sale of $3.9M TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.98 | 48,515 | $1.9M | 50.0% |
| 2 | $39.98 | 48,515 | $1.9M | 50.0% |
| Total | $39.98 avg | 97,030 | $3.9M | 100% |
| Filing → |
| TMDX | SELL | 2024-05-03 | $3.0M | — | Filing → |
| TMDX | SELL | 2024-03-05 | $2.2M | — | Filing → |
| TMDX | SELL | 2023-11-29 | $701K | — | Filing → |